Skip to content

AUPH

Aurinia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$16.49
−0.12%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
22.90x
P/E 2026E
17.52x
P/E 2027E
14.04x
P/E 2028E
11.51x
P/S forward
6.25x

Trailing multiples

Trailing twelve months

P/E TTM
6.99x
PEG TTM
—
Price / book
3.57x
Price / sales
7.04x
Price / cash flow
12.63x

Enterprise value

Enterprise value
$1.8B
EV / sales
5.81x
EV / EBITDA
9.62x
EV / EBIT
12.02x
Market cap
$2.2B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026